Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion
HC Diener, R Bernstein, K Butcher, B Campbell, G Cloud, A Davalos, S Davis, JM Ferro, M Grond, D Krieger, G Ntaios, A Slowik, E Touze
International Journal of Stroke | SAGE PUBLICATIONS LTD | Published : 2017
Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.
Awarded by Alberta Innovates